Document 0923 DOCN M94A0923 TI Risk factors for HIV seroconversion in commercial sex workers in Mombasa, Kenya: role of hormonal contraception & STDs. DT 9412 AU Martin HL Jr; Nyange PM; Jackson DJ; Mandaliya K; Holmes KK; Ngugi E; Ndinya-Achola JO; Plummer F; Kreiss J; University of Washington, Seattle 98195. SO Int Conf AIDS. 1994 Aug 7-12;10(2):25 (abstract no. 394C). Unique Identifier : AIDSLINE ICA10/94371652 AB OBJECTIVES: To define the incidence and risk factors for HIV infection in a high risk population of commercial sex workers (CSW's) and to establish a cohort for future prophylactic HIV vaccine trials. METHODS: Prospective cohort study in women registered as CSW's in a municipal clinic. RESULTS: Between February 1993 and February 1994, 1585 women were counselled and screened for HIV. Seroprevalence of HIV was 56.5%, and 435 seronegative women were enrolled. Mean age was 28 years; mean duration of prostitution was 6 years. Mean sexual frequency was 1.6/week with 1 partner/week. Mean condom use was 63%, and the average charge for sex was KSh 638/= (US$9.5). Incidence of STD's was: gonorrhea 121/100 p-y, trichomonas 56/100 p-y, genital ulcers 20/100 p-y, chlamydia 16/100 p-y. Twenty-seven subjects seroconverted for HIV, an incidence rate of 16.2/100 p-y. Compared to women remaining uninfected with HIV, seroconverters had fewer sexual partners/week (0.6 vs 1.0, p = .02) and lower sexual frequency/week (1.0 vs 1.6, p = .01). There was no difference in age, mean charge for sex, years of education, or reported condom use. HIV acquisition was associated with the use of oral contraceptives (OR 2.6, 1.0-6.8) and depo provera (OR 3.7, 1.4-9.6), presence of genital ulcers (OR 3.7, 1.4-9.9), gonorrhea (OR 2.2, CI 1.2-3.7), and vaginal discharge (OR 2.0, 1.2-3.4). Trends towards positive associations with HIV seroconversion were found with vulvitis (OR 1.9, 0.8-5.0) and cervicitis (OR 1.5, 0.9-2.4). CONCLUSION: In this prospective study, HIV seroconversion was significantly associated with the use of oral contraceptives and depo provera, genital ulcers, gonorrhea, and vaginal discharge. DE Cohort Studies Comorbidity *Contraceptives, Oral, Hormonal Disease Susceptibility Drug Utilization Female Gonorrhea/EPIDEMIOLOGY Human HIV Seropositivity/*EPIDEMIOLOGY Kenya/EPIDEMIOLOGY Leukorrhea/EPIDEMIOLOGY *Medroxyprogesterone 17-Acetate Occupational Diseases/*EPIDEMIOLOGY Odds Ratio Prospective Studies Prostitution/*STATISTICS & NUMER DATA Risk Factors Sexually Transmitted Diseases/*EPIDEMIOLOGY Ulcer/EPIDEMIOLOGY Urban Population MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).